![](https://ml.globenewswire.com/media/ZWZmOWQ3ODktYjdhNS00YzMxLTg0OWUtNDE4Yzc5MWQxMTcwLTUwMDEzMjE0NA==/tiny/Drugs-Made-In-America-Acquisit.png)
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
Fort Lauderdale, Florida, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that the underwriter of its previously announced initial public offering fully exercised its option to …